Phase II Studies of Gemcitabine and Cisplatin in Heavily and Minimally Pretreated Metastatic Breast Cancer

PURPOSE: Cisplatin and gemcitabine have single-agent activity in metastatic breast cancer, and preclinical data support synergy of the combination. Two parallel, phase II trials were conducted to evaluate the response rate, response duration, and toxicities of the combination. Genetic polymorphisms...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Chew, Helen K., Doroshow, James H., Frankel, Paul, Margolin, Kim A., Somlo, George, Lenz, Heinz-Josef, Gordon, Michael, Zhang, Wu, Yang, Dongyun, Russell, Christy, Spicer, Darcy, Synold, Tim, Bayer, Robert, Hantel, Alexander, Stiff, Patrick J., Tetef, Merry L., Gandara, David R., Albain, Kathy S.
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Clinical Oncology 2009
Fag:
Original Reports
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2674003/
https://ncbi.nlm.nih.gov/pubmed/19307510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.17.4839
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker